Last reviewed · How we verify

single injection nerve block

University of California, San Diego · FDA-approved active Small molecule

A single injection nerve block temporarily interrupts nerve signal transmission to provide localized anesthesia and pain relief.

A single injection nerve block temporarily interrupts nerve signal transmission to provide localized anesthesia and pain relief. Used for Perioperative pain management and anesthesia, Chronic pain conditions requiring regional anesthesia.

At a glance

Generic namesingle injection nerve block
SponsorUniversity of California, San Diego
Drug classLocal anesthetic nerve block
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

Nerve blocks work by delivering local anesthetic agents directly around peripheral nerves, blocking the conduction of pain signals from a specific anatomical region. This approach provides targeted anesthesia without systemic effects, allowing for pain control during and after procedures or for chronic pain management. The effect is temporary, lasting from hours to days depending on the anesthetic agent and formulation used.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: